NO984195D0 - Nye benzofuranonderivater og fremgangsmåte for fremstilling derav - Google Patents

Nye benzofuranonderivater og fremgangsmåte for fremstilling derav

Info

Publication number
NO984195D0
NO984195D0 NO984195A NO984195A NO984195D0 NO 984195 D0 NO984195 D0 NO 984195D0 NO 984195 A NO984195 A NO 984195A NO 984195 A NO984195 A NO 984195A NO 984195 D0 NO984195 D0 NO 984195D0
Authority
NO
Norway
Prior art keywords
preparation
derivatives
new
benzofuranone
benzofuranone derivatives
Prior art date
Application number
NO984195A
Other languages
English (en)
Other versions
NO319608B1 (no
NO984195L (no
Inventor
Makoto Yoshihama
Masamichi Nakakoshi
Junji Nakamura
Shoji Nakayama
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO984195D0 publication Critical patent/NO984195D0/no
Publication of NO984195L publication Critical patent/NO984195L/no
Publication of NO319608B1 publication Critical patent/NO319608B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO19984195A 1997-01-14 1998-09-11 Nye benzofuranonderivater, farmasoytisk preparat inneholdende samme samt anvendelse av samme for fremstilling av medikament NO319608B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1599197 1997-01-14
JP22556597A JP3783810B2 (ja) 1997-01-14 1997-08-08 新規ベンゾフラノン誘導体及びその製造方法
PCT/JP1998/000090 WO1998030556A1 (fr) 1997-01-14 1998-01-13 Nouveaux derives de benzofuranone et procede d'elaboration

Publications (3)

Publication Number Publication Date
NO984195D0 true NO984195D0 (no) 1998-09-11
NO984195L NO984195L (no) 1998-10-26
NO319608B1 NO319608B1 (no) 2005-08-29

Family

ID=26352227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984195A NO319608B1 (no) 1997-01-14 1998-09-11 Nye benzofuranonderivater, farmasoytisk preparat inneholdende samme samt anvendelse av samme for fremstilling av medikament

Country Status (18)

Country Link
US (1) US6143779A (no)
EP (1) EP0902022B1 (no)
JP (1) JP3783810B2 (no)
KR (1) KR100293907B1 (no)
CN (1) CN1173964C (no)
AT (1) ATE246180T1 (no)
AU (1) AU717159B2 (no)
CA (1) CA2248953C (no)
DE (1) DE69816731T2 (no)
DK (1) DK0902022T3 (no)
ES (1) ES2203921T3 (no)
HU (1) HUP9901616A3 (no)
IL (1) IL126137A (no)
NO (1) NO319608B1 (no)
NZ (1) NZ331857A (no)
PT (1) PT902022E (no)
RU (1) RU2152391C1 (no)
WO (1) WO1998030556A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4166433B2 (ja) * 1997-09-11 2008-10-15 第一製薬株式会社 ホルモン依存性疾患治療剤
US7465739B2 (en) 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
CN101014327A (zh) * 2004-07-14 2007-08-08 詹森药业有限公司 用于治疗雌激素相关α受体介导的疾病的亚芳基类物质
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
CA2644809A1 (en) * 2006-03-02 2007-09-07 Astellas Pharma Inc. 17 .beta. hsd type 5 inhibitor
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
US20110158908A1 (en) 2007-08-24 2011-06-30 Sapporo Medical University Cyclosporin a-binding protein
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
US20090192147A1 (en) * 2008-01-30 2009-07-30 Wyeth [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
WO2009155052A1 (en) * 2008-05-28 2009-12-23 Wyeth 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
CA2723279A1 (en) * 2008-05-28 2009-12-23 Wyeth Llc 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
EP2326631A4 (en) * 2008-08-18 2012-03-21 Univ Yale MODULATORS OF MIF
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2565192B9 (en) 2010-04-30 2015-11-25 The University of Tokyo Anticancer agent
CN111801097A (zh) * 2018-01-22 2020-10-20 肯塔基大学研究基金会 半合成噢哢及其使用方法
CN115925665A (zh) * 2022-12-09 2023-04-07 中国药科大学 一种pde4抑制剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975380A (en) * 1974-06-03 1976-08-17 Smithkline Corporation Substituted aurones
US5354861A (en) * 1992-11-04 1994-10-11 National University Of Singapore 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents
JP3872834B2 (ja) * 1996-03-04 2007-01-24 第一製薬株式会社 メイラード反応抑制剤

Also Published As

Publication number Publication date
CA2248953C (en) 2003-09-09
KR20000064582A (ko) 2000-11-06
CA2248953A1 (en) 1998-07-16
AU717159B2 (en) 2000-03-16
EP0902022A4 (en) 2002-01-23
DK0902022T3 (da) 2003-11-24
CN1173964C (zh) 2004-11-03
AU5343698A (en) 1998-08-03
HUP9901616A1 (hu) 2001-04-28
HUP9901616A3 (en) 2001-05-28
RU2152391C1 (ru) 2000-07-10
KR100293907B1 (ko) 2001-09-17
EP0902022B1 (en) 2003-07-30
CN1217719A (zh) 1999-05-26
NO319608B1 (no) 2005-08-29
ATE246180T1 (de) 2003-08-15
WO1998030556A1 (fr) 1998-07-16
NO984195L (no) 1998-10-26
JPH10259182A (ja) 1998-09-29
NZ331857A (en) 2000-02-28
DE69816731D1 (de) 2003-09-04
PT902022E (pt) 2003-12-31
JP3783810B2 (ja) 2006-06-07
EP0902022A1 (en) 1999-03-17
ES2203921T3 (es) 2004-04-16
IL126137A (en) 2006-08-01
US6143779A (en) 2000-11-07
IL126137A0 (en) 1999-05-09
DE69816731T2 (de) 2004-06-03

Similar Documents

Publication Publication Date Title
NO984195D0 (no) Nye benzofuranonderivater og fremgangsmåte for fremstilling derav
SE9600406D0 (sv) Novel coompounds
FI905280A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista bentsopyridopiperidiini-, piperidylideeni- ja -piperatsiiniyhdistettä
BG105177A (en) Novel substituted pyrazole derivatives
NO20024772L (no) Percyquinnin, fremgangsmÕte for dets fremstilling og dets anvendelse som et legemiddel
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
SE8902264D0 (sv) 2-(5-fluoronikotinoyl)-aettiksyraderivat och foerfarande foer framstaellning av detta
CY1109832T1 (el) Επεξεργασια τρυγικης φορμοτερολης και πολυμορφο
NO965334L (no) Nye 4,6-diarylpyrimidin-derivater og salter derav
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE425973T1 (de) Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
NO984532D0 (no) Nye tetralon- eller benzopyranonderivater og fremgangsmÕte for fremstilling derav
DK0388956T3 (da) Phtalinidderivat, farmaceutisk præparat og anvendelse
DK546489D0 (da) Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme
DK0428878T3 (da) Benzocycloalkylaminopyridinaminer og beslægtede forbindelser, fremgangsmåde til deres fremstilling, mellemprodukter og deres anvendelse som lægemidler
ATE100097T1 (de) Benzoxepin-derivate.
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
NO994131L (no) Fremgangsmaate for fremstilling av benzotiazolonforbindelser
WO2003087035A8 (en) 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
CY1107483T1 (el) Παραγωγα πυριδαζινης, η χρηση τους ως φαρμακευτικα σκευασματα και η διαδικασια παρασκευης τους
MX9205408A (es) Metodo para tratar hipertension.